Trademark: 97236398
Word
CSL BEHRING
Status
Pending
Status Code
730
Status Date
Monday, January 8, 2024
Serial Number
97236398
Mark Type
4000
Filing Date
Tuesday, January 25, 2022
Published for Opposition
Tuesday, June 13, 2023

Trademark Owner History
CSL Behring L.L.C. - Owner At Publication

Classifications
5 Pharmaceutical preparations for blood diseases, illnesses and conditions; Pharmaceutical preparations for the treatment or prevention of blood and bleeding disorders; diagnostic preparation for medicinal purposes; Pharmaceutical preparations for immunology, hematology, respiratory, albumin, transplant, inflammatory, and cardiovascular diseases, illnesses, or conditions; Human blood plasma derived pharmaceutical preparations for the treatment of a wide variety of diseases, illnesses or conditions; Pharmaceutical preparations for the treatment of infectious diseases, and diseases caused by bacteria and viruses; vaccines; medicated serums for the treatment of influenza; anti-virals; influenza vaccines; adjuvants and antigens for medical purposes; pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases; pharmaceutical preparations, namely, reagents for medical and clinical use for typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes

Trademark Events
Jan 10, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2024
Sou Extension 1 Granted
Jan 8, 2024
Sou Extension 1 Filed
Jan 8, 2024
Sou Teas Extension Received
Aug 8, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 13, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 13, 2023
Published For Opposition
May 24, 2023
Notification Of Notice Of Publication E-Mailed
May 9, 2023
Exparte Appeal Terminated
May 9, 2023
Approved For Pub - Principal Register
May 8, 2023
Ex Parte Appeal-Instituted
May 8, 2023
Jurisdiction Restored To Examining Attorney
May 8, 2023
Exparte Appeal Received At Ttab
Apr 27, 2023
Teas Request For Reconsideration Received
Feb 8, 2023
Notification Of Final Refusal Emailed
Feb 8, 2023
Final Refusal E-Mailed
Feb 8, 2023
Final Refusal Written
Jan 19, 2023
Teas/Email Correspondence Entered
Jan 18, 2023
Correspondence Received In Law Office
Jan 18, 2023
Teas Response To Office Action Received
Jul 19, 2022
Notification Of Non-Final Action E-Mailed
Jul 19, 2022
Non-Final Action E-Mailed
Jul 19, 2022
Non-Final Action Written
Jul 11, 2022
Assigned To Examiner
Jan 28, 2022
New Application Office Supplied Data Entered
Jan 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24